New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

Neuromuscular disorders can be caused by hereditary or acquired genetic mutations, impairing the function of skeletal muscles: those under voluntary control. These diseases cause muscles to weaken and ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

A research team led by Biological Sciences Asst. Prof. Nicolai Konow will work across disciplines to develop a deeper understanding of how muscles function. “Everything has to be broken down to its ...

They embrace effort. They run parkrun, climb stairs deliberately, and value the feeling of being challenged – slightly ...

Researchers successfully developed and validated a new outcome measure to monitor disease severity and progression in patients with impaired skeletal muscle function caused by mitochondrial disease.

Proteins are essential for body growth and muscle building. However, protein metabolism varies depending on the body’s internal biological clock. Therefore, it is important to know how distribution of ...

You’re relaxing on the sofa when suddenly your eyelid starts twitching. Or perhaps it’s a muscle in your arm, your leg, or your foot that begins to spasm – sometimes for a few seconds, sometimes for ...